Céline E. Toutain

569 total citations
17 papers, 442 citations indexed

About

Céline E. Toutain is a scholar working on Molecular Biology, Pharmacology and Small Animals. According to data from OpenAlex, Céline E. Toutain has authored 17 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Small Animals. Recurrent topics in Céline E. Toutain's work include Inflammatory mediators and NSAID effects (4 papers), Drug-Induced Adverse Reactions (3 papers) and Estrogen and related hormone effects (3 papers). Céline E. Toutain is often cited by papers focused on Inflammatory mediators and NSAID effects (4 papers), Drug-Induced Adverse Reactions (3 papers) and Estrogen and related hormone effects (3 papers). Céline E. Toutain collaborates with scholars based in France, United States and Switzerland. Céline E. Toutain's co-authors include Jean‐François Arnal, Françoise Lenfant, Pierre Gourdy, Wolfgang Seewald, Martin Jung, Coralie Fontaine, Andrée Krust, Pierre Chambon, Hortense Bergès and Alain‐Pierre Gadeau and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Céline E. Toutain

15 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Céline E. Toutain France 10 149 133 88 45 40 17 442
Shaojia Bao United States 8 71 0.5× 100 0.8× 56 0.6× 55 1.2× 22 0.6× 12 488
Zhaoying Xiang United States 14 60 0.4× 180 1.4× 57 0.6× 74 1.6× 85 2.1× 19 552
Zhiguang Zhou China 13 133 0.9× 184 1.4× 112 1.3× 22 0.5× 140 3.5× 53 508
Shoshana Israel Israel 12 137 0.9× 228 1.7× 117 1.3× 42 0.9× 44 1.1× 29 488
Meiting Wu United States 13 110 0.7× 354 2.7× 31 0.4× 45 1.0× 75 1.9× 20 771
Renata Dellalibera-Joviliano Brazil 12 121 0.8× 150 1.1× 21 0.2× 33 0.7× 90 2.3× 33 528
Amy J. Swift United States 12 198 1.3× 291 2.2× 33 0.4× 24 0.5× 124 3.1× 18 800
Qiang Wei China 13 68 0.5× 135 1.0× 90 1.0× 19 0.4× 17 0.4× 49 442
Yun Guo China 13 57 0.4× 186 1.4× 47 0.5× 31 0.7× 43 1.1× 38 603

Countries citing papers authored by Céline E. Toutain

Since Specialization
Citations

This map shows the geographic impact of Céline E. Toutain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline E. Toutain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline E. Toutain more than expected).

Fields of papers citing papers by Céline E. Toutain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Céline E. Toutain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline E. Toutain. The network helps show where Céline E. Toutain may publish in the future.

Co-authorship network of co-authors of Céline E. Toutain

This figure shows the co-authorship network connecting the top 25 collaborators of Céline E. Toutain. A scholar is included among the top collaborators of Céline E. Toutain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Céline E. Toutain. Céline E. Toutain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Toutain, Céline E., et al.. (2025). Pharmacokinetics of Ilunocitinib, a New Janus Kinase Inhibitor, in Dogs. Journal of Veterinary Pharmacology and Therapeutics. 49(1). 7–16.
2.
Toutain, Céline E., et al.. (2025). Safety of ilunocitinib tablets (Zenrelia™) after once daily oral administration in dogs. BMC Veterinary Research. 21(1). 144–144. 4 indexed citations
3.
4.
Hansen, Tina Vicky Alstrup, Heinz Sager, Céline E. Toutain, et al.. (2022). The Caenorhabditis elegans DEG-3/DES-2 Channel Is a Betaine-Gated Receptor Insensitive to Monepantel. Molecules. 27(1). 312–312. 4 indexed citations
5.
Heit, Mark C., et al.. (2020). Safety evaluation of the interchangeable use of robenacoxib in commercially-available tablets and solution for injection in cats. BMC Veterinary Research. 16(1). 355–355. 2 indexed citations
6.
Toutain, Céline E., Wolfgang Seewald, & Martin Jung. (2018). Pharmacokinetics of lotilaner following a single oral or intravenous administration in cats. Parasites & Vectors. 11(1). 412–412. 13 indexed citations
7.
Toutain, Céline E., et al.. (2018). Six-month safety evaluation of robenacoxib tablets (Onsior™) in dogs after daily oral administrations. BMC Veterinary Research. 14(1). 242–242. 6 indexed citations
8.
Toutain, Céline E., Wolfgang Seewald, & Martin Jung. (2017). The intravenous and oral pharmacokinetics of lotilaner in dogs. Parasites & Vectors. 10(1). 522–522. 43 indexed citations
9.
Toutain, Céline E., et al.. (2017). Safety evaluation of the interchangeable use of robenacoxib (Onsior™) tablets and solution for injection in dogs. BMC Veterinary Research. 13(1). 359–359. 9 indexed citations
10.
Adlanmérini, Marine, Frédéric Boudou, Élodie Chantalat, et al.. (2017). Testosterone Prevents Cutaneous Ischemia and Necrosis in Males Through Complementary Estrogenic and Androgenic Actions. Arteriosclerosis Thrombosis and Vascular Biology. 37(5). 909–919. 16 indexed citations
11.
Bornkamp, Björn, et al.. (2016). Multiple comparison procedure and modeling: a versatile tool for evaluating dose–response relationships in veterinary pharmacology – a case study with furosemide. Journal of Veterinary Pharmacology and Therapeutics. 39(6). 539–546. 5 indexed citations
12.
Valera, Marie‐Cécile, Marie‐Pierre Gratacap, Pierre Gourdy, et al.. (2012). Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the hematopoietic estrogen receptor α. Blood. 120(8). 1703–1712. 50 indexed citations
13.
Toutain, Céline E., et al.. (2011). Paw Inflammation Model in Dogs for Preclinical Pharmacokinetic/Pharmacodynamic Investigations of Nonsteroidal Anti-Inflammatory Drugs. Journal of Pharmacology and Experimental Therapeutics. 338(2). 548–558. 30 indexed citations
14.
Billon-Galés, Audrey, Andrée Krust, Coralie Fontaine, et al.. (2011). Activation function 2 (AF2) of estrogen receptor-α is required for the atheroprotective action of estradiol but not to accelerate endothelial healing. Proceedings of the National Academy of Sciences. 108(32). 13311–13316. 99 indexed citations
15.
Toutain, Céline E., Cédric Filipe, Coralie Fontaine, et al.. (2009). Estrogen Receptor α Expression in Both Endothelium and Hematopoietic Cells Is Required for the Accelerative Effect of Estradiol on Reendothelialization. Arteriosclerosis Thrombosis and Vascular Biology. 29(10). 1543–1550. 45 indexed citations
16.
Conte, Caroline, Élodie Riant, Céline E. Toutain, et al.. (2008). FGF2 Translationally Induced by Hypoxia Is Involved in Negative and Positive Feedback Loops with HIF-1α. PLoS ONE. 3(8). e3078–e3078. 65 indexed citations
17.
Toutain, Céline E., L. Brouchet, Isabelle Raymond‐Letron, et al.. (2008). Prevention of Skin Flap Necrosis by Estradiol Involves Reperfusion of a Protected Vascular Network. Circulation Research. 104(2). 245–254. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shaojia Bao Breakdown of academic impact, for papers by Zhaoying Xiang Breakdown of academic impact, for papers by Zhiguang Zhou Breakdown of academic impact, for papers by Shoshana Israel Breakdown of academic impact, for papers by Meiting Wu Breakdown of academic impact, for papers by Renata Dellalibera-Joviliano Breakdown of academic impact, for papers by Amy J. Swift Breakdown of academic impact, for papers by Qiang Wei Breakdown of academic impact, for papers by Yun Guo
Rankless by CCL
2026